Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Difluoromethoxy-benzaldehyde oxime is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

97603-92-4

Post Buying Request

97603-92-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97603-92-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97603-92-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,6,0 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 97603-92:
(7*9)+(6*7)+(5*6)+(4*0)+(3*3)+(2*9)+(1*2)=164
164 % 10 = 4
So 97603-92-4 is a valid CAS Registry Number.

97603-92-4Relevant articles and documents

Stereospecific 1,4-Metallate Shift Enables Stereoconvergent Synthesis of Ketoximes

Yang, Kai,Zhang, Feng,Fang, Tongchang,Zhang, Guan,Song, Qiuling

supporting information, p. 13421 - 13426 (2019/08/20)

Reported herein is a stereospecific 1,4-metallate rearrangement for single-geometry ketoxime synthesis from oxime chlorides and arylboronic acids. This strategy exhibits broad substrate scope with excellent stereoselectivity under mild reaction conditions. In comparison with the conventional approaches, each configuration of unsymmetric diaryl oximes, as well as the thermodynamically less stable Z isomer of aryl alkyl ketoximes can be selectively and exclusively obtained. The reactivities of unsymmetric diaryl oximes and the Z isomer of aryl alkyl oximes, a class of underexplored molecules, enables efficient access to the corresponding isoquinolines, isoquinoline N-oxides, and amides having a single configuration.

Preparation of Triazolopyrimidines as Potential Antiasthma Agents

Medwid, Jeffrey B.,Paul, Rolf,Baker, Jannie S.,Brockman, John A.,Du, Mila T.,et al.

, p. 1230 - 1241 (2007/10/02)

With the use of the human basophil histamine release assay, 5-aryl-2-aminotriazolopyrimidines were found to be active as mediator release inhibitors.These compounds were prepared by reacting arylamidines with sodium ethyl formylacetate or with ethyl propiolate to give pyrimidinones.Treatment with phosphorus oxychloride gave a chloropyrimidine, which was converted to a hydrazinopyrimidine with hydrazine.Cyclization, using cyanogen bromide, gave the triazolopyrimidines, after a Dimroth rearrangement.Following a structure-activity evaluation, the5--2-amino (8-10), 5-(3-bromophenyl)-2-amino (8-13), 5--2-amino (8-11), and 5-(4-pyridinyl)-2-amino (6-7) compounds were found to have the best activity.They were chosen for further pharmacological and toxicological study.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 97603-92-4